QUEBEC CITY, QC, Dec. 11 /PRNewswire-FirstCall/ -- AEterna Zentaris Inc. (TSX: AEZ; Nasdaq: AEZS) today announced that its Executive Vice President, Global R&D and COO, Dr. Jurgen Engel, will be a participant on the Cancer Horoscope: Future Treatments panel on Thursday, December 14, 2006 at 10:00 a.m. Eastern, as part of the 2006 RBC Capital Markets Healthcare Conference which will be held at the Westin New York at Times Square Hotel in New York City. A live webcast of this presentation will be available on AEterna Zentaris' website at http://www.aeternazentaris.com/ in the Investors section. A replay will also be available for a period of 30 days. About AEterna Zentaris Inc. AEterna Zentaris Inc. is a growing global biopharmaceutical company focused on endocrine therapy and oncology, with proven expertise in drug discovery, development and commercialization. News releases and additional information are available at http://www.aeternazentaris.com/. DATASOURCE: AETERNA ZENTARIS INC. CONTACT: Media Relations: Paul Burroughs, (418) 652-8525, ext. 406, ; Investor Relations: Jenene Thomas, (418) 655-6420, (908) 996-3154,

Copyright